---
layout: post
title: "Medicare Program; Inflation Reduction Act (IRA) Medicare Drug Price Negotiation Program Final Guidance"
date: 2026-02-04 21:46:52 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2025-21501
original_published: 2025-11-28 00:00:00 +0000
significance: 8.00
---

# Medicare Program; Inflation Reduction Act (IRA) Medicare Drug Price Negotiation Program Final Guidance

**Published:** February 04, 2026 21:46 UTC
**Source:** Federal Register
**Original Published:** November 28, 2025 00:00 UTC
**Document Number:** 2025-21501

## Summary

The Centers for Medicare & Medicaid Services (CMS) is announcing the availability of CMS' final guidance for the third cycle of the Medicare Drug Price Negotiation Program (hereafter the "Negotiation Program"), the first cycle of renegotiation, and manufacturer effectuation of the maximum fair price (MFP) in 2026, 2027, and 2028 for the implementation of the Inflation Reduction Act of 2022 (IRA) (Pub. L. 117-169). This and other IRA-related guidance can be viewed on the dedicated IRA section of the CMS website at https:// www.cms.gov/inflation-reduction-act-and-medicare/

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2025/11/28/2025-21501/medicare-program-inflation-reduction-act-ira-medicare-drug-price-negotiation-program-final-guidance)
- API: https://www.federalregister.gov/api/v1/documents/2025-21501

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
